131 related articles for article (PubMed ID: 36974802)
21. Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction.
van Kempen LC; Nelissen JM; Degen WG; Torensma R; Weidle UH; Bloemers HP; Figdor CG; Swart GW
J Biol Chem; 2001 Jul; 276(28):25783-90. PubMed ID: 11306570
[TBL] [Abstract][Full Text] [Related]
22. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
24. Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
Arnold Egloff SA; Du L; Loomans HA; Starchenko A; Su PF; Ketova T; Knoll PB; Wang J; Haddad AQ; Fadare O; Cates JM; Lotan Y; Shyr Y; Clark PE; Zijlstra A
Oncotarget; 2017 Jan; 8(1):722-741. PubMed ID: 27894096
[TBL] [Abstract][Full Text] [Related]
25. ALCAM/CD166: cancer-related issues.
Weidle UH; Eggle D; Klostermann S; Swart GW
Cancer Genomics Proteomics; 2010; 7(5):231-43. PubMed ID: 20952758
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes.
Rauch SJ; Rosenkranz AC; Böhm A; Meyer-Kirchrath J; Hohlfeld T; Schrör K; Rauch BH
Vascul Pharmacol; 2011; 54(3-6):93-9. PubMed ID: 21440089
[TBL] [Abstract][Full Text] [Related]
27. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.
Kijima N; Hosen N; Kagawa N; Hashimoto N; Nakano A; Fujimoto Y; Kinoshita M; Sugiyama H; Yoshimine T
Neuro Oncol; 2012 Oct; 14(10):1254-64. PubMed ID: 22166264
[TBL] [Abstract][Full Text] [Related]
28. Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis.
van Kempen LC; Meier F; Egeblad M; Kersten-Niessen MJ; Garbe C; Weidle UH; Van Muijen GN; Herlyn M; Bloemers HP; Swart GW
J Invest Dermatol; 2004 May; 122(5):1293-301. PubMed ID: 15140234
[TBL] [Abstract][Full Text] [Related]
29. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.
Kim YS; Kim MN; Lee KE; Hong JY; Oh MS; Kim SY; Kim KW; Sohn MH
Clin Exp Immunol; 2018 May; 192(2):151-164. PubMed ID: 29363753
[TBL] [Abstract][Full Text] [Related]
30. Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.
Miccichè F; Da Riva L; Fabbi M; Pilotti S; Mondellini P; Ferrini S; Canevari S; Pierotti MA; Bongarzone I
PLoS One; 2011 Feb; 6(2):e17141. PubMed ID: 21364949
[TBL] [Abstract][Full Text] [Related]
31. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.
Piao D; Jiang T; Liu G; Wang B; Xu J; Zhu A
Mol Biol Rep; 2012 Jan; 39(1):661-8. PubMed ID: 21670959
[TBL] [Abstract][Full Text] [Related]
33. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody.
Piazza T; Cha E; Bongarzone I; Canevari S; Bolognesi A; Polito L; Bargellesi A; Sassi F; Ferrini S; Fabbi M
J Cell Sci; 2005 Apr; 118(Pt 7):1515-25. PubMed ID: 15769845
[TBL] [Abstract][Full Text] [Related]
34. ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.
Jannie KM; Stipp CS; Weiner JA
PLoS One; 2012; 7(6):e39330. PubMed ID: 22745734
[TBL] [Abstract][Full Text] [Related]
35. ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
Tachezy M; Effenberger K; Zander H; Minner S; Gebauer F; Vashist YK; Sauter G; Pantel K; Izbicki JR; Bockhorn M
Int J Cancer; 2012 Jul; 131(2):396-405. PubMed ID: 21858815
[TBL] [Abstract][Full Text] [Related]
36. Activated leukocyte cell adhesion molecule is a marker for thyroid carcinoma aggressiveness and disease-free survival.
Chaker S; Kak I; MacMillan C; Ralhan R; Walfish PG
Thyroid; 2013 Feb; 23(2):201-8. PubMed ID: 23148625
[TBL] [Abstract][Full Text] [Related]
37. Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166).
Fujiwara H; Tatsumi K; Kosaka K; Sato Y; Higuchi T; Yoshioka S; Maeda M; Ueda M; Fujii S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3437-43. PubMed ID: 12843199
[TBL] [Abstract][Full Text] [Related]
38. Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy.
Te Riet J; Zimmerman AW; Cambi A; Joosten B; Speller S; Torensma R; van Leeuwen FN; Figdor CG; de Lange F
J Cell Sci; 2007 Nov; 120(Pt 22):3965-76. PubMed ID: 17971418
[TBL] [Abstract][Full Text] [Related]
39. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
40. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
